Metabolic & Weight Management
AOD-9604
A GH-fragment signal used for fat-mobilization research.
Last updated
Mechanism
Supports lipolysis signaling through the GH C-terminal fragment.
Reported effects
What sources associate with this compound. Reported categories, not outcomes we have graded — each would need its own citation and rung.
- Fat mobilization
- Cut-phase support
- No expected hyperglycemia
Dosing on file unverified
250-500 mcg daily, cycled 12–16 weeks
| Reported dose | Volume | Draw |
|---|---|---|
| Low — 250 mcg | 0.25 mL | 25 units |
| High — 500 mcg | 0.5 mL | 50 units |
What that assumes. Assumes 2 mg in 2 mL (1000 mcg/mL) drawn on a U-100 barrel — the preset on this record, not a recommendation and not the only way to mix it. Change the vial mass, the diluent or the barrel and every number in this table changes. Run your own.
Carried from a source that labels it unverified, and reproduced with that label attached. A record of what is reported, not a recommendation. No citation on this page establishes it.
Reconstitution
| Vial | Diluent | Concentration | Typical dose | Draw |
|---|---|---|---|---|
| 2 mg | 2 mL | 1000 mcg/mL | 250 mcg | 25 units |
mass ÷ diluent = concentration; dose ÷ concentration = volume; volume × the syringe factor = units on the barrel (100 for U-100, 40 for U-40). Run your own numbers.
Reported adverse effects
-
No expected effect on blood glucose
Literature on file 6
-
human case series
Identification and characterization of peptide drugs in unknown pharmaceutical preparations seized by the Belgian authorities: case report on AOD9604. graded on: a case report or series — “case report”
Not graded
5 citations whose study design could not be read from the title. Left ungraded rather than guessed at.
- not graded
- not graded
- not graded
- not graded
- not graded
Identity
Skeletal formulathe canonical depiction
Drawn by PubChem from CID 71300630, the identifier on this record.
- Molecular weight
- 1815.1
- Molecular formula
- C78H123N23O23S2
- CAS number
- 221231-10-3
- PubChem CID
- 71300630
- InChI key
- GVIYUKXRXPXMQM-BPXGDYAESA-N
- Sequence
- YLRIVQCRSVEGSCGF
- SMILES
- CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCCNC(=N)N)CO)C(C)C)CCC(=O)O)CO)C(=O)NCC(=O)N[C@@H](CC2=CC=CC=C2)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CC=C(C=C3)O)N
- InChI
- InChI=1S/C78H123N23O23S2/c1-9-41(8)62(101-68(115)47(18-14-28-86-78(83)84)91-69(116)50(29-38(2)3)95-63(110)45(79)30-43-19-21-44(104)22-20-43)75(122)100-61(40(6)7)74(121)94-49(23-25-56(80)105)67(114)98-55-37-126-125-36-54(65(112)88-32-57(106)89-51(76(123)124)31-42-15-11-10-12-16-42)97-70(117)52(34-102)90-58(107)33-87-64(111)48(24-26-59(108)109)93-73(120)60(39(4)5)99-71(118)53(35-103)96-66(113)46(92-72(55)119)17-13-27-85-77(81)82/h10-12,15-16,19-22,38-41,45-55,60-62,102-104H,9,13-14,17-18,23-37,79H2,1-8H3,(H2,80,105)(H,87,111)(H,88,112)(H,89,106)(H,90,107)(H,91,116)(H,92,119)(H,93,120)(H,94,121)(H,95,110)(H,96,113)(H,97,117)(H,98,114)(H,99,118)(H,100,122)(H,101,115)(H,108,109)(H,123,124)(H4,81,82,85)(H4,83,84,86)/t41-,45-,46-,47-,48-,49-,50-,51-,52-,53-,54-,55-,60-,61-,62-/m0/s1
Classified as
- Lipolysis Stimulationmechanism
- This mechanism is the source of the most common category error on the site. A record can be well supported for lipolysis and carry nothing at all for fat loss, and the two live in different fields with different rungs on the ladder at /evidence/rubric.
- Subcutaneousroute
- This is the route the reconstitution arithmetic assumes. Mass divided by diluent volume gives concentration, dose divided by concentration gives volume, and volume in mL multiplied by 100 gives units on a U-100 barrel: 5 mg in 2 mL is 2.5 mg/mL, and 0.25 mg comes out at 0.1 mL, which is 10 units.
Also called
- AOD-9604
Notes unverified prose
Preclinical / Small human studies; no Phase 3 trials; Phase 2B trial (Metabolic Pharmaceuticals); 12-week RCT in obese adults
Not on file 0
All 8 tracked fields hold a value on this record: molecular weight and formula, CAS number, PubChem CID, amino-acid sequence, SMILES, InChI and InChI key.
Counted from the record itself, not from what a source said it was missing. 136 of 185 records still have at least one empty.
Listed prices 10
What 10 shops we track listed for AOD-9604, read from their own public catalogues on 2026-08-12. We take no commission on these and they are not ranked by any payment — how vendors are scored.
| Vendor | Size | Price | Per mg |
|---|---|---|---|
| Particle Peptides Canada | 5 mg | $35.88 CAD | $7.18/mg |
| Amino Peptides | 10 mg | $84.99 CAD | $8.50/mg |
| Core Peptides Canada | 5 mg | $50.55 CAD | $10.11/mg |
| Peptide Shop Canada | size not listed | $25.00 CAD | — |
| Vendor | Size | Price | Per mg |
|---|---|---|---|
| Core Peptides | 5 mg | $41.00 USD | $8.20/mg |
| Biotech Peptides | 5 mg | $44.00 USD | $8.80/mg |
| Raw Amino | 5 mg | $50.00 USD | $10.00/mg |
| ResearchChemical.com | 5 mg | $74.99 USD | $15.00/mg |
| Vendor | Size | Price | Per mg |
|---|---|---|---|
| Toronto Peptides | size not listed | 56.00 (currency not stated) |
— |
| Riptide Peptides | size not listed | 69.00 (currency not stated) | — |
None of these shops lists your destination. Choose “Show all” to see every listing we hold.
Prices are the vendor's own listing, reproduced with the date we read it — never converted between currencies, and compared per milligram only where the vendor states the vial size.
Share this record
